2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC1913
Submitter : Dr. Tony Ogburn Date & Time: 10/31/2005 04:10:33
Organization : Dr. Tony Ogburn
Category : Health Professional
Issue Areas/Comments
The continued delays in allowing over the counter sales of Plan B are clearly not related to real scientific concerns but purely political. It is a travesty. I truly believe that if it didn't have to do with sex and limited to women it would not be an issue.